Nephrogenex: Jefferies Global Healthcare Conference (Nephrogenex) - Jun 8, 2014 - "Nephrogenex Phase 2a PYR-205-207"; "Pyridorin at a 250 mg bid dose is well tolerated and slows the rate of SCr increase in moderate to advanced disease patients"
P2 data • Diabetic Nephropathy • Renal Disease
|